[1] |
|
[2] |
Yang A, Zhang P, Sun Z, et al. Lysionotin induces apoptosis of hepatocellular carcinoma cells via caspase-3 mediated mitochondrial pathway[J]. Chem Biol Interact, 2021, 344: 109500. DOI: 10.1016/j.cbi.2021.109500.
|
[3] |
|
[4] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
[5] |
Chen H, Jia W. Progress in hepatectomy for hepatocellular carcinoma and peri-operation management[J]. Genes Dis, 2020, 7(3): 320-327. DOI: 10.1016/j.gendis.2020.02.001.
|
[6] |
Fuks D, Cauchy F, Ftériche S, et al. Laparoscopy decreases pulmonary complications in patients undergoing major liver resection: a propensity score analysis[J]. Ann Surg, 2016, 263(2): 353-361. DOI: 10.1097/SLA.0000000000001140.
|
[7] |
Famularo S, Donadon M, Cipriani F, et al. The impact of postoperative ascites on survival after surgery for hepatocellular carcinoma: a national study[J]. J Gastrointest Surg, 2021, 25(11): 2823-2834. DOI: 10.1007/s11605-021-04952-z.
|
[8] |
|
[9] |
Yoshikawa T, Nomi T, Hokuto D, et al. Risk factors for postoperative ascites in patients undergoing liver resection for hepatocellular carcinoma[J]. World J Surg, 2017, 41(8): 2095-2100. DOI: 10.1007/s00268-017-4003-x.
|
[10] |
单文刚, 曹宽, 刘志毅, 等. 原发性肝癌患者行解剖性肝切除术后大量腹水的危险因素分析[J]. 徐州医科大学学报, 2022, 42(8): 571-575.
|
[11] |
Harimoto N, Araki K, Ishii N, et al. Predictors of postoperative ascites after hepatic resection in patients with hepatocellular carcinoma[J]. Anticancer Res, 2020, 40(8): 4343-4349. DOI: 10.21873/anticanres.14437.
|
[12] |
Itoh S, Uchiyama H, Ikeda Y, et al. Post-hepatectomy refractory ascites in cirrhotic patients with hepatocellular carcinoma: risk factor analysis to overcome this problematic complication[J]. Anticancer Res, 2017, 37(3): 1381-1385. DOI: 10.21873/anticanres.11459.
|
[13] |
Qian HG, Wu LY, Li CP, et al. A novel scoring system to predict ascites development post hepatectomy for BCLC stage B hepatocellular carcinoma[J]. Translational Cancer Research, 2018, 7(1): 180-188. DOI: 10.21037/tcr.2018.01.35.
|
[14] |
|
[15] |
Li C, Zhang JY, Zhang XY, et al. FibroScan predicts ascites after liver resection for hepatitis B virus-related hepatocellular carcinoma: a prospective cohort study[J]. Int J Surg, 2015, 20: 21-25. DOI: 10.1016/j.ijsu.2015.05.047.
|
[16] |
Xu HW, Liu F, Li HY, et al. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis[J]. Surg Endosc, 2018, 32(2): 712-719. DOI: 10.1007/s00464-017-5727-2.
|
[17] |
Chiejina M, Kudaravalli P, Samant H. Ascites[M]. Treasure Island (FL): StatPearls Publishing, 2022.
|
[18] |
|
[19] |
Moore CM, Van Thiel DH. Cirrhotic ascites review: pathophysiology, diagnosis and management[J]. World J Hepatol, 2013, 5(5): 251-263. DOI: 10.4254/wjh.v5.i5.251.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2): 406-460. DOI: 10.1016/j.jhep.2018.03.024.
|
[24] |
Saner FH, Stueben BO, Hoyer D, et al. Use or misuse of albumin in critical ill patients[J]. Diseases, 2023, 11(2): 68. DOI: 10.3390/diseases11020068.
|
[25] |
|
[26] |
|
[27] |
|
[28] |
Zhao H, Wu L, Yan G, et al. Inflammation and tumor progression: signaling pathways and targeted intervention[J]. Signal Transduct Target Ther, 2021, 6(1): 263. DOI: 10.1038/s41392-021-00658-5.
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|